Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS Cyanobacteria, secondary metabolites

ABSTRACT:

INSTRUMENT(S): LTQ Advantage Max spectrometer

ORGANISM(S): Marine Cyanobacteria

SUBMITTER: Valerie Paul

PROVIDER: MSV000078681 | GNPS | Mon May 26 06:34:00 BST 2014

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Functional genomics of novel secondary metabolites from diverse cyanobacteria using untargeted metabolomics.

Project description: Not available

| S-EPMC3826126 | biostudies-literature

Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria.

Project description: Not available

| S-EPMC2890784 | biostudies-literature

Role of toxic and bioactive secondary metabolites in colonization and bloom formation by filamentous cyanobacteria Planktothrix.

Project description: Not available

| S-EPMC4892429 | biostudies-literature

Metabolomic profiling of twenty metabolites from human tissues in six studies

Project description:Twenty metabolites across 6 studies, with 6 groups of experimental subjects

2008-06-21 | E-TABM-290 | biostudies-arrayexpress

Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites.

Project description: Not available

| S-EPMC3542135 | biostudies-literature

Reactivity of Cyanobacteria Metabolites with Ozone: Multicompound Competition Kinetics.

Project description: Not available

| S-EPMC11223487 | biostudies-literature

Molluscicidal metabolites from an assemblage of Palmyra Atoll cyanobacteria.

Project description: Not available

| S-EPMC3227552 | biostudies-literature

Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence

Project description:Staphylococcus aureus is a major human pathogen and resistant to numerous clinically used antibiotics. The first antibiotic developed for S. aureus infections was the nonribosomal petide secondary metabolite penicillin. We discovered cryptic nonribosomal peptide secondary metabolites, the aureusimines, made by S. aureus itself that are not antibiotics, but function as small molecule regulators of virulence factor expression. Using established rules and codes for nonribosomal peptide assembly we predicted these nonribosomal peptides, and used these predictions to identify them from S. aureus culture broths. Functional studies using global microarray and mouse bacteremia models established that the aureusimines control virulence factor expression and are necessary for productive infections. This is the first report of the aureusimines and has important implications for the treatment of drug resistant S. aureus. Targeting aureusimine synthesis may provide novel anti-infectives. Commerically available S. aureus GeneChips (Affymetrix) were used to compare biological replicates of early and late exponential phase wild type (Newman) and aureusimine defective (ausA) organisms.

2010-07-30 | E-GEOD-21373 | biostudies-arrayexpress

Secondary Metabolites of Purpureocilliumlilacinum.

Project description: Not available

| S-EPMC8746413 | biostudies-literature

Staphylococcus aureus nonribosomal peptide secondary metabolites regulate virulence

2010-07-01 | GSE21373 | GEO